Stockholders approve reverse stock split at ratio of 1-for-3 to 1-for-30

Lunai Bioworks Inc.

Proposal 1 (reverse split) approved: 13,571,288 for, 1,153,415 against, 61,177 abstentions.
Proposal 2 (adjournment) approved: 13,626,029 for, 1,091,528 against, 68,323 abstentions.
Exact split ratio between 1:3 and 1:30 to be set by Board; intended to regain Nasdaq bid price compliance.

item 5.07

Lunai Bioworks Inc. filing history →

Source: SEC EDGAR

accession 0001731122-26-000718

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.